Clinicopathologic significance of BAG1 and TIMP3 expression in colon carcinoma

World J Gastroenterol. 2007 Jul 28;13(28):3883-5. doi: 10.3748/wjg.v13.i28.3883.

Abstract

Aim: To explore the expression of BAG1 and tissue inhibitor of metalloproteinase 3 (TIMP3) in colon carcinoma and their correlation and clinicopathologic significance.

Methods: SABC immunohistochemistry was used to detect the expression of BAG1 and TIMP3 in 80 colon carcinoma tissues and 20 normal colonic mucosa.

Results: Positive rate of BAG1 in colon carcinoma tissue (80%) was notably higher compared to normal colonic mucosa (10%) (P < 0.05). However, no significant difference was observed in positive rate of TIMP3 in colon carcinoma tissue (43.75%) as compared with normal colonic mucosa (60%) (P > 0.05). Expression of BAG1 and TIMP3 was strongly associated with colon carcinoma differentiation, Duke's staging, lymph node metastasis and survival rate (P < 0.05), but not associated with gender and age. Moreover, BAG1 expression was not correlated with TIMP3.

Conclusion: Our results suggest that over-expression of BAG1 or attenuated expression of TIMP3 may play an important role in genesis and development of colon carcinoma. The protein expression levels of BAG1 and TIMP3 are related to the malignant degree, infiltration and metastasis of colon carcinoma. BAG1 and TIMP3 might be new biological parameters in predicting invasion and metastasis of colon carcinoma.

MeSH terms

  • Adenocarcinoma / diagnosis
  • Adenocarcinoma / metabolism*
  • Cell Transformation, Neoplastic / metabolism*
  • Colonic Neoplasms / diagnosis
  • Colonic Neoplasms / metabolism*
  • DNA-Binding Proteins / metabolism*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Tissue Inhibitor of Metalloproteinase-3 / metabolism*
  • Transcription Factors / metabolism*

Substances

  • BCL2-associated athanogene 1 protein
  • DNA-Binding Proteins
  • TIMP3 protein, human
  • Tissue Inhibitor of Metalloproteinase-3
  • Transcription Factors